Table 1.
Patient 1 | Patient 2 | Patient 3 | Mean | |
---|---|---|---|---|
Age | 27 | 29 | 47 | 34.33 |
Ethnicity | Black | White | White | |
BMI | 27.1 | 28 | 26.3 | 27.13 |
Comorbidities | N/A | N/A | N/A | |
ECOG performance status | 0 | 0 | 0 | |
CPS score | 0 | 0 | 0 | |
Stage at Diagnosis | IIB | IB1 | IVB | |
Prior Regimens | cis/RT + brachy | cis/RT + brachy | carbo/taxol + EBRT | |
carbo/taxol/bev | carbo/taxol/bev | bev | ||
cemiplimab | ||||
Line of therapy | 4.00 | 3.00 | 3.00 | 3.33 |
Histology | SCC | Adenocarcinoma | Gastric type | |
HPV | + | 18+ | neg | |
Time to PR (mos) | 2.00 | 2.00 | N/A | 2.00 |
Time to CR (mos) | 4.00 | 6.00 | 3.00 | 4.33 |